Is MRNA stock a Buy, Sell, or Hold?

Based on our analysis, MRNA is currently a HOLD with moderate confidence. 📊 HOLD: MRNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

What is the fair value of MRNA stock?

Our analysis estimates the fair value range for MRNA to be between $54.22 and $71.40. The current price is $59.81.

What is the analyst price target for MRNA?

The average Wall Street analyst price target for MRNA is $50.84. This implies a potential upside of -5.6% from current levels.

MRNA Stock Analysis: Buy, Sell, or Hold?

MRNA - Moderna, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

$59.81

0.64 (1.08%) ▲

5d: +8.47%

30d: -12.39%

90d: +10.05%

HOLD

MODERATE Confidence

Protect Your MRNA Gains

Analysis Updated: Aug 10, 2026 12:00 AM ET

Earnings: Jul 31, 2026 0d

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Aug 7, 2026 at $59.17 · last confirmed Aug 10, 2026

Strength: 8.0/10

Get Alerted When MRNA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: MRNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: MRNA is currently trading at $59.81, which is considered fair relative to its 30-day fair value range of $54.22 to $71.40.

Technical Outlook: Technically, MRNA is in a uptrend. The price is approaching resistance at $60.77. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR

Historical Trading Range $54.22 - $71.40

Company Quality Score 55/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 66.8%

Protect Your Profits

Holding MRNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

NEUTRAL: Price in fair range
NEUTRAL: Mixed technical signals (57/100)
BULLISH: High volume confirmation
BEARISH: Trading above Wall St target ($50.84)
NEUTRAL: Bottoming setup forming (57/100) — watch for confirmation

Trading Range Analysis

30-Day Trading Range $54.22 - $71.40

Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $52.66

Resistance Level $60.77

Current Trend Uptrend

Technical data as of Aug 10, 2026

Fundamental Context

Forward P/E (Next Year Est.) -10.96

Wall Street Target $50.84 (-5.6%)

Revenue Growth (YoY) 2.1%

Earnings Growth (YoY) -85.1%

Profit Margin -141.4%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: August 10, 2026 8:54 PM ET
Data refreshes hourly during market hours. Next update: 9:54 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is MRNA showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Stephen Hoge SELL 160009 shares 2026-02-23

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for MRNA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
ALNY Alnylam Pharmaceuticals …	STRONG BUY 30 analysts	$376	53 HOLD
ONC BeiGene, Ltd.	STRONG BUY 24 analysts	$431	43 HOLD
ASND Ascendis Pharma AS	STRONG BUY 16 analysts	$309	63 BUY
VRTX Vertex Pharmaceuticals I…	BUY 34 analysts	$559	40 SELL
APLS Apellis Pharmaceuticals …	BUY 22 analysts	$41	50 HOLD

ALNY Alnylam Pharmaceu…

53 HOLD

ONC BeiGene, Ltd.

43 HOLD

ASND Ascendis Pharma AS

63 BUY

VRTX Vertex Pharmaceut…

40 SELL

APLS Apellis Pharmaceu…

50 HOLD

Advanced MRNA Option Strategies

Professional options setups generated by AI based on today's MRNA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for MRNA

MRNA Technical Chart MRNA Price Prediction MRNA Earnings Date MRNA Investment Advisor MRNA Fair Price Analyzer MRNA Options Advisor MRNA Options Chain MRNA Options Analysis MRNA Competitors

Compare MRNA with Peers

MRNA vs NVAX
Which one to buy?

MRNA vs BNTX
Which one to buy?

MRNA vs ZM
Which one to buy?

MRNA vs AZN
Which one to buy?

MRNA vs NIO
Which one to buy?

IBRX vs MRNA
Winner: Tie

INO vs MRNA

Create New Comparison View All Competitors

Tradestie